Skip to content
Home
About CancerNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
About CancerNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Activity Type
Enduring
Live in-person
Live Webinar
Credit Type
AACE
AANP
ACPE
ANCC
CME
COPE
CPE
MOC
NCPD
Profession
Nurses
Nurse Practitioner
Optometrist
Others
Pharmacist
Physician
Physician Assistant
Specialty
Allergy and Immunology
Anesthesiology
Cardiology
Dermatology
Family Medicine
Gastroenterology
Geriatrics
Hematology/Oncology
Infectious Disease
Nephrology
Neurology
Oncology
Ophthalmology
Otolaryngology (ENT)
Palliative Medicine
Pathology
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Sleep Medicine
Urology
Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Enduring Webcast
Read more
PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer – Enduring Webcast
Read more
Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Enduring Webcast
Read more
Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Enduring Webcast
Read more
Myelofibrosis: Symptom Burden, Risk Stratification, and Novel Treatments – Enduring Webcast
Read more
Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy – Enduring Webcast
Read more
Evolving Paradigm of PARP-Inhibitors and Combination Therapies for mCRPC – Enduring Webcast
Read more
Changing Landscape of Diagnosis and Treatment Options for Multiple Myeloma – Enduring Webcast
Read more
Emerging Strategies in the Immune Checkpoint Inhibitors (ICIs) and the Synergistic Effect of Antibody-Drug Conjugate in Combination with ICIs for Urothelial Carcinoma – Enduring Webcast
Read more
Hepatocellular Carcinoma: Immune Checkpoint Inhibitors, Multi-Targeted Tyrosine Kinase Inhibitors and the Combination Thereof – Enduring Webcast
Read more
Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Enduring Webcast
Read more
New Strategies in the Diagnosis and Treatment of Follicular Lymphoma: 2022 ASH Update – Enduring Webcast
Read more
Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma) – Enduring Webcast
Read more
Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy – Enduring Webcast
Read more
Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma – Enduring Webcast
Read more
Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors – Enduring Webcast
Read more
1
2
3
4
Next »
Scroll To Top
